Careers  |  Sign In  |  Register

Latest in Ophthalmology

Reuters Health • The Doctor's Channel Daily Newscast

Three-year screening interval for diabetic retinopathy appears safe

NEW YORK (Reuters Health) – Patients with type 2 diabetes without retinopathy can be safely screened for sight-threatening vision problems every 3 years instead of every 1 or 2 years, researchers from Sweden conclude based on a study they conducted. Screening for diabetic retinopathy is “highly...

Reuters Health • The Doctor's Channel Daily Newscast

Another anti-VEGF drug showing promise for diabetic macular edema

NEW YORK (Reuters Health) - In a phase 2 study of patients with diabetic macular edema (DME), intravitreal injections of the vascular endothelial growth factor inhibitor, VEGF Trap-Eye, proved superior to macular laser treatment, researchers report. “The results of this clinical trial,” they say,...

Reuters Health • The Doctor's Channel Daily Newscast

Topical lubricants, steroids may help dry eye due to Sjögren’s syndrome

NEW YORK (Reuters Health) – Eye drops containing lubricants, corticosteroids, cyclosporine, or autologous serum improve dry eye symptoms associated with Sjögren’s syndrome (SS), according to a literature review. Evidence also showed some benefit from plugging the tear duct and from systemic drugs that...